High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors
- 2 February 1982
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 21 (3) , 567-572
- https://doi.org/10.1021/bi00532a024
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.Journal of Biological Chemistry, 1977
- Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.Journal of Clinical Investigation, 1977
- Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.Proceedings of the National Academy of Sciences, 1976
- Antithrombin-heparin cofactor: An inhibitor of plasma kallikreinArchives of Biochemistry and Biophysics, 1976
- Etude du complexe plasmine-α2-macroglobuline de porcBiochimica et Biophysica Acta (BBA) - Enzymology, 1976
- Large scale purification of α2-macroglobulin from human plasmaBiochemical Medicine, 1975
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966
- Esters of Methanesulfonic Acid as Irreversible Inhibitors of AcetylcholinesteraseJournal of Biological Chemistry, 1962
- PROTEIN BINDING OF PANCREATIC PROTEOLYTIC ENZYMES*Journal of Clinical Investigation, 1962
- Assay and Properties of Serum Inhibitor of C'1-EsteraseExperimental Biology and Medicine, 1959